Brain Changes Seen in Breast-Cancer Survivors

November 15, 2011


Getty Images
By Anne Harding

TUESDAY, November 15, 2011 ( — Many cancer survivors report feeling they’ve lost some mental sharpness following treatment. This common phenomenon has come to be known as “chemo brain” or “chemo fog,” which is somewhat misleading because it also occurs in people who have not undergone chemotherapy.

Although recent studies have shown that up to 75% of cancer survivors do indeed experience altered mental function—and that these changes can last for five years or longer—doctors often downplay complaints about chemo fog, says Shelli R. Kesler, PhD, of the Stanford Cancer Center, in Palo Alto, Calif.

“[Patients] often are told it’s not real, they’re imagining it, it’s just due to stress,” she says.

In a new study published this week in the Archives of Neurology, Kesler and her colleagues provide more evidence that the phenomenon is real. Using brain scans, the researchers found that breast-cancer survivors show changes in key aspects of mental function that can translate to real-world difficulties. And these changes were particularly marked in women who had undergone chemotherapy.

Kesler’s team investigated prefrontal-executive function, the type of mental activity most commonly reported to go awry in breast-cancer patients. Executive function includes the ability to selectively pay attention, work with information, and choose the appropriate response while suppressing inappropriate responses.

The study included 25 breast-cancer patients who had undergone chemo, 19 breast-cancer survivors who didn’t get chemo, and 18 healthy women. While undergoing functional magnetic resonance imaging (fMRI) brain scans, the participants completed a brainteaser in which they tried to discern a pattern in a series of cards printed with colorful geometric shapes. The test, Kesler explains, measures “cognitive flexibility,” or the ability to identify the best solution to a problem by mentally testing several possibilities.

Overall, both groups of breast-cancer patients showed less activity than the control group in regions of the brain involved in executive-function tasks such as storing and processing information. And the chemo-treated patients displayed the least activity of any group in parts of the brain associated with cognitive flexibility—a result that was borne out by the card-sorting task. The chemo patients made the most mistakes on the task, on average, and they took the most time to complete it.

The brain activity of the chemo patients was also closely correlated with how severe they judged their own post-treatment declines in mental function to be. This finding confirms that chemo fog is not imaginary, says Robert Ferguson, PhD, a clinical psychologist at Eastern Maine Medical Center, in Bangor, who studies the phenomenon but was not involved in the new research.

“I have patients tell me, ‘I’m just working harder and I’m slower at what I do, and I have to check my work and I still find errors, even when I’m working methodically,'” Ferguson says. “This data is consistent with that anecdotal report.”

Next page: Chemo’s not the only explanation

Powered by VIP